-
2
-
-
0003637883
-
Expert Panel 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-summary report 2007
-
National Asthma Education and Prevention Program, [erratum, J Allergy Clin Immunol 2008;121:1330.]
-
National Asthma Education and Prevention Program. Expert Panel 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-summary report 2007. J Allergy Clin Immunol 2007;120(suppl):S94-S138. [erratum, J Allergy Clin Immunol 2008;121:1330.]
-
(2007)
J Allergy Clin Immunol
, vol.120
, Issue.SUPPL.
-
-
-
3
-
-
84875134036
-
2010 Top 200 branded drugs by total prescriptions
-
(accessed 2012 Mar 26)
-
2010 Top 200 branded drugs by total prescriptions. Drug Topics http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drug topics/252011/727256/article.pdf (accessed 2012 Mar 26).
-
Drug Topics
-
-
-
4
-
-
0036178365
-
Misues of corticosteroid metered-dose inhaler is associated with decreased asthma stability
-
Giraud V, Roche N. Misues of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19:246-51.
-
(2002)
Eur Respir J
, vol.19
, pp. 246-251
-
-
Giraud, V.1
Roche, N.2
-
5
-
-
84875161640
-
-
United States Environmental Protection Agency, (accessed May 2)
-
Metered dose inhalers: the transition to ozone-safe propellants. United States Environmental Protection Agency. http://www.epa.gov/ozone/title6/exemptions/inhalers.html (accessed 2012 May 2).
-
(2012)
Metered dose inhalers: The transition to ozone-safe propellants
-
-
-
7
-
-
30444452988
-
Regional lung deposition and bronchodilator response as a function of beta-2 agonist particle size
-
Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta-2 agonist particle size. Am J Respir Crit Care Med 2005;172;1497-504.
-
(2005)
Am J Respir Crit Care Med
, vol.172
, pp. 1497-1504
-
-
Usmani, O.S.1
Biddiscombe, M.F.2
Barnes, P.J.3
-
8
-
-
0029845201
-
Glucocorticoid receptor localization in normal and asthmatic lung
-
Adcock IM, Gibley T, Gelder CM, Chung KF, Barnes PJ. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996;154:771-82.
-
(1996)
Am J Respir Crit Care Med
, vol.154
, pp. 771-782
-
-
Adcock, I.M.1
Gibley, T.2
Gelder, C.M.3
Chung, K.F.4
Barnes, P.J.5
-
9
-
-
84875188909
-
-
Qvar, (accessed Sep 19). Horsham, PA. 8/08
-
Qvar. Teva Specialty Pharmaceuticals LLC. Horsham, PA. 8/08. http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020911s017lbl.pdf (accessed 2012 Sep 19).
-
(2012)
Teva Specialty Pharmaceuticals LLC
-
-
-
10
-
-
84875163710
-
-
Sepracor Inc, (accessed Sep 19). Marlborough, MA. 5/2008
-
Alvesco. Sepracor Inc. Marlborough, MA. 5/2008. http://www.accessdata. fda.gov/drugsatfda_docs/label/2008/021658s002lbl.pdf (accessed 2012 Sep 19).
-
(2012)
Alvesco
-
-
-
11
-
-
0032438394
-
Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone
-
Leach CL, Davidson PJ, Bourdeau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12:1346-53.
-
(1998)
Eur Respir J
, vol.12
, pp. 1346-1353
-
-
Leach, C.L.1
Davidson, P.J.2
Bourdeau, R.J.3
-
12
-
-
0033408351
-
Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans
-
Leach C. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol 1999;104:S250-2.
-
(1999)
J Allergy Clin Immunol
, vol.104
-
-
Leach, C.1
-
13
-
-
0036036475
-
Lung deposition of HFA beclomethasone is greater than that of CFC-fluticasone and CFC-beclomethasone: A cross-over study in healthy volunteers
-
Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of HFA beclomethasone is greater than that of CFC-fluticasone and CFC-beclomethasone: a cross-over study in healthy volunteers. Chest 2002;122:510-6.
-
(2002)
Chest
, vol.122
, pp. 510-516
-
-
Leach, C.L.1
Davidson, P.J.2
Hasselquist, B.E.3
Boudreau, R.J.4
-
14
-
-
29844448453
-
Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler
-
Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler. J Aerosol Med 2005;18:379-85.
-
(2005)
J Aerosol Med
, vol.18
, pp. 379-385
-
-
Leach, C.L.1
Davidson, P.J.2
Hasselquist, B.E.3
Boudreau, R.J.4
-
15
-
-
78649940445
-
A pilot study to assess lung deposition of HFAbeclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times
-
Leach CL, Colice GL. A pilot study to assess lung deposition of HFAbeclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times. J Aerosol Med Pulm Drug Deliv 2010;23:355-61.
-
(2010)
J Aerosol Med Pulm Drug Deliv
, vol.23
, pp. 355-361
-
-
Leach, C.L.1
Colice, G.L.2
-
16
-
-
34250796234
-
The potential of a 2-tone training to help patients use their metered-dose inhalers
-
Al-Showair RAM, Pearson SB, Chrystyn H. The potential of a 2-tone training to help patients use their metered-dose inhalers. Chest 2007;131: 1776-82.
-
(2007)
Chest
, vol.131
, pp. 1776-1782
-
-
Al-Showair, R.A.M.1
Pearson, S.B.2
Chrystyn, H.3
|